€8.6 Million Follow On Offering of Quantum Genomics SA

Represented Maxim Group LLC and Invest Securities SA as placement agents in the €8.6 million follow-on offering of Paris Alternext-listed Quantum Genomics SA, a biopharmaceutical company whose purpose is to develop new therapies for unmet medical needs in the field of cardiovascular diseases. The transaction was a unit offering of ordinary shares and warrant and conducted as a private placement in the United States.